July 2025 – PHAGElogist

Adoption of phage therapy in the US

Exploration of Providers’ Perceptions and Attitudes Toward Phage Therapy and Intentions for Future Adoption as an Alternative to Traditional Antibiotics in the US—A Cross-Sectional Study Abstract Antibiotic resistance presents a…

TechnoPhage & PHAXIAM Therapeutics partner to improve phage therapy

TechnoPhage, a Portuguese company specialising in GMP phage development, and PHAXIAM Therapeutics, a biopharmaceutical firm focused on innovative treatments for severe and resistant bacterial infections, announced a strategic collaboration. This partnership aims…

Let’s meet in Knoxville!

19 Jul 202519 Jul 2025

I will be attending the "Evergrenn Phage Meeting" in Knoxville, Tennessee. We can meet if you are in... https://foodscience.tennessee.edu/phage/ I will be presenting about the ssRNA phages and their lysis…

Human serum affect sensitivity to phage infection

An interesting observation from Campobasso et al. "Human serum lipids affect Staphylococcus aureus sensitivity to phage infection" Adult human serum in vitro prevents phage lytic activity against S. aureus Foetal calf serum does not affect…

Phage therapy suitability to a patient: A lesson to learn

6 Jul 20256 Jul 2025

How to: assess patient suitability for unlicensed phage therapy in the United Kingdom Phage therapy may be used as an unlicensed medicine in the United Kingdom Naturally occurring phages are…